Other Events ·
PDS Biotechnology to host virtual event on Oct 15 featuring NCI investigator discussing Phase 2 mCRC data
PDSBPDS Biotechnology Corp
PDS Biotechnology announced it will host a virtual key opinion leader event on October 15, 2026. The company plans to feature Jonathan M. Hernandez, M.D., an investigator with the Surgical Oncology Program at the National Cancer Institute’s Center for Cancer Research. Dr. Hernandez will join management to discuss clinical outcomes from the PDS0301 Phase 2 trials for advanced liver-associated cancers, specifically focusing on the metastatic colorectal cancer cohort. The event aims to provide an overview of trial results in patients with unresectable microsatellite stable or mismatch repair-proficient colorectal liver metastases. PDS Biotechnology is a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer.